Mandate

Vinge has advised Titania Holding AB (publ) in connection with its listing on Nasdaq First North Growth Market

Vinge has advised Titania Holding AB (publ) (“Titania”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 29 November 2021 and the first day of trading was 10 December 2021.

The price in the offering was SEK 20 per class B share, corresponding to a market capitalization of all of Titania’s shares upon completion of the offering of approximately SEK 1.4 billion.

Titania is a fast-growing real estate company focusing on the Stockholm region. Its operations consist of project development, production and management. Titania participates throughout the entire value chain, from early stages of city and project development to land acquisitions, production and rental and eventually also long-term property management. Titania possesses expertise throughout all steps of the value chain and has capacity to carry out large projects within urban development, adding value in terms of increased social and financial sustainability.

Vinge’s team primarily consisted of David Andersson, Amanda Knutsson, Anna Grigorian and Anna Svensson (Capital Markets and Public M&A), Frida Ställborn (Real Estate), Kamyar Najmi and Benjamin Vafaeian (Banking and Finance).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025